Read More
Newsletter Signup | Join Community | Cancer Types
ASCO Update of IMpassion130 clinical trial: Tecentriq improves outcomes of Triple Negative Breast Cancer
MedMaven
Jun 1, 2019
New England Journal of Medicine study updates promising activity of Sacituzumab treatment for triple neg breast cancer.
Cancer Connect
Feb 21, 2019
Aug 23, 2019
by
mary care
Neoadjuvant Keytruda, Tecentriq, and Sacituzumab Govitecan (IMMU-132) are promising TNBC treatment advances.
Feb 4, 2020
Dr. Bhuvaneswari Ramaswamy of the OSU Arthur G. James Cancer Hospital answers frequently asked questions about TNBC
Feb 1, 2020
Dec 21, 2019
WilliamHodgetts
Stay Current With Triple-Negative Breast Cancer Treatment Advances & Connect with Others
TraceyS
Feb 4, 2019
Iniparib Promising in Metastatic Triple-negative Breast Cancer
Aug 28, 2018
Obesity Linked with Triple-Negative Breast Cancer
Erbitux May Increase Response Rates in Metastatic Triple-Negative Breast Cancer.
Aug 14, 2019
mary john
Triple Negative Breast Cancer Linked with Higher Rate of Distant Metastases.
Aug 27, 2018
Jul 30, 2019
Is anyones doctor recommending treatment with a checkpoint inhibitor? These seem like they coul...
Oct 29, 2018
Interesting data published this week show HDC appears to benefit TNBC: https://mavendoctors…
